Patent Assignment
Reel/Frame 023166/0937
Change of Name
Recorded: 2009-08-28
Pages: 4
Assignor
IDEC PHARMACEUTICALS CORP.
Executed: 2003-11-12
Assignee
BIOGEN IDEC INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Treatment of Hematologic Malignancies Associated with Circulating Tumor Cells Using Chimeric Anti-CD20 Antibody
Patent:
7,682,612 →
Application:
09/436,347 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 22, 1999
From: WHITE, CHRISTINE A; GRILLO-LOPEZ, ANTONIO J.
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 010464/0829 →
Assignment of Assignor's Interest
Nov 10, 2009
From: CURD, JOHN G.; DESMOND-HELLMANN, SUSAN
To: GENENTECH, INC.
Reel/Frame 023504/0449 →
Change of Name
Apr 30, 2015
From: BIOGEN IDEC INC.
To: BIOGEN INC.
Reel/Frame 035552/0202 →